Sean Lavin
Stock Analyst at BTIG
(3.08)
# 1,284
Out of 5,072 analysts
45
Total ratings
81.82%
Success rate
38.68%
Average return
Main Sectors:
Stocks Rated by Sean Lavin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TCMD Tactile Systems Technology | Downgrades: Neutral | n/a | $26.06 | - | 4 | Nov 5, 2024 | |
| HOLX Hologic | Downgrades: Neutral | n/a | $74.88 | - | 5 | Jul 18, 2022 | |
| PODD Insulet | Upgrades: Buy | $320 | $328.82 | -2.68% | 5 | Feb 3, 2022 | |
| MDT Medtronic | Downgrades: Neutral | n/a | $105.35 | - | 1 | Jan 10, 2022 | |
| ATRC AtriCure | Maintains: Buy | $42 → $48 | $38.48 | +24.74% | 3 | Feb 19, 2020 | |
| MASI Masimo | Downgrades: Neutral | n/a | $146.49 | - | 4 | Apr 16, 2019 | |
| HSDT Solana Company | Downgrades: Neutral | n/a | $3.59 | - | 4 | Apr 16, 2019 | |
| IRTC iRhythm Technologies | Upgrades: Buy | $80 | $188.30 | -57.51% | 3 | Apr 3, 2019 | |
| NEO NeoGenomics | Upgrades: Outperform | n/a | $12.34 | - | 4 | Apr 16, 2018 | |
| EXAS Exact Sciences | Upgrades: Buy | n/a | $101.13 | - | 3 | Apr 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $128.05 | - | 1 | Jan 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $101.36 | - | 1 | Nov 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $61.69 | - | 3 | May 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $86.82 | - | 4 | Feb 2, 2017 |
Tactile Systems Technology
Nov 5, 2024
Downgrades: Neutral
Price Target: n/a
Current: $26.06
Upside: -
Hologic
Jul 18, 2022
Downgrades: Neutral
Price Target: n/a
Current: $74.88
Upside: -
Insulet
Feb 3, 2022
Upgrades: Buy
Price Target: $320
Current: $328.82
Upside: -2.68%
Medtronic
Jan 10, 2022
Downgrades: Neutral
Price Target: n/a
Current: $105.35
Upside: -
AtriCure
Feb 19, 2020
Maintains: Buy
Price Target: $42 → $48
Current: $38.48
Upside: +24.74%
Masimo
Apr 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $146.49
Upside: -
Solana Company
Apr 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $3.59
Upside: -
iRhythm Technologies
Apr 3, 2019
Upgrades: Buy
Price Target: $80
Current: $188.30
Upside: -57.51%
NeoGenomics
Apr 16, 2018
Upgrades: Outperform
Price Target: n/a
Current: $12.34
Upside: -
Exact Sciences
Apr 3, 2018
Upgrades: Buy
Price Target: n/a
Current: $101.13
Upside: -
Jan 22, 2018
Downgrades: Neutral
Price Target: n/a
Current: $128.05
Upside: -
Nov 30, 2017
Upgrades: Buy
Price Target: n/a
Current: $101.36
Upside: -
May 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $61.69
Upside: -
Feb 2, 2017
Downgrades: Neutral
Price Target: n/a
Current: $86.82
Upside: -